Hyein Jeong

7PUBLICATIONS
16CO-AUTHORS
Haematological tumoursTumour immunologyPredictive and prognostic markersInnate immunityMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2024
Increased CCL2/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC/BCL2 double-expressor DLBCL.

Sehui Kim, Hyein Jeong, Hyun Kyung Ahn

|Sep 05, 2024
Spatially Resolved Whole-Transcriptomic and Proteomic Profiling of Lung Cancer and Its Immune Microenvironment According to PD-L1 Expression.

Jaemoon Koh, Dongjoo Lee, Sehui Kim

|Jul 30, 2024
Correction: Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.

Hyein Jeong, Jaemoon Koh, Sehui Kim

|May 10, 2024
Epithelial-mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer.

Hyein Jeong, Jaemoon Koh, Sehui Kim

|Jan 27, 2022
Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy.

Hyein Jeong, So-Young Lee, Hyejun Seo

|Aug 14, 2021
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model.

Hyein Jeong, So-Young Lee, Hyejun Seo

Pageof 2

Frequent Collaborators

4 joint publications

Yoon Kyung Jeon

3 joint publications

Bum-Joon Kim

3 joint publications

Bhumsuk Keam

3 joint publications

Se-Hoon Lee